Pfizer exits China joint venture for generic drugs

Pfizer exits China joint venture for generic drugs

The Pfizer logo is pictured at their building in the Manhattan borough of New York October 29, 2015. REUTERS/Carlo Allegri

Pfizer Inc said on Friday it has sold its 49 percent stake to exit a joint venture it had set up with China’s Zhejiang Hisun Pharmaceuticals in 2012 to develop and market generic drugs.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter